Trivalent split Inf

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

6 competitors in Immunology

#DrugCompanyPhaseTrials

1

Nonavalent HPV Vaccine

XXiamen University

Phase 3

12

Trivalent split Inf

Sanofi

Phase 3

13

Flumist

AstraZeneca

Phase 1

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Influenza20 trials

High Dose Influenza in Immunosuppressed Subjects

Withdrawn·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00766285

TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza B

Unknown status·BBritish Columbia Centre for Disease Control··NCT01067404·50 enrolled

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

Completed·UUniversity of Witwatersrand, South Africa·Phase 4·NCT01812980·105 enrolled

Show 17 more trials

Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

Completed·Sinovac Biotech Co., Ltd·Phase 4·NCT01008137·150 enrolled

Influenza Vaccine in Pediatric Transplant Subjects

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00133510·60 enrolled

2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT01173211·183 enrolled

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

Completed·UUniversity Health Network, Toronto·Phase 4·NCT00402805·50 enrolled

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

Completed·—·N/A·NCT00570037·544 enrolled

Th1 Response to Influenza: Aging and Vaccine Efficacy

Terminated·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00396305·41 enrolled

A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age

Completed·Sanofi·Phase 2·NCT01258595·300 enrolled

Influenza Vaccine in Premature Infants

Completed·UUniversity of Rochester··NCT00455169·66 enrolled

Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00307177·28 enrolled

Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00307710·28 enrolled

Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.

Completed·MMahidol University·Phase 4·NCT02101749·221 enrolled

Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older

Terminated·Sanofi·Phase 3·NCT00976027·9,172 enrolled

Evaluation of a School-based Influenza Vaccination Program

Completed·CCenters for Disease Control, Taiwan·Phase 4·NCT00961337·7,854 enrolled

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Completed·SStanford University·Phase 4·NCT01827462·136 enrolled

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT01181323·240 enrolled

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

Completed·JJohns Hopkins Bloomberg School of Public Health·N/A·NCT01522248·20 enrolled

Proteomic Profiling for Influenza

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00133588·150 enrolled

Flu Vaccine2 trials

Comparison of Delivery Routes of Flu Vaccine in Adults

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00170547·1,597 enrolled

Comparison of Flu Vaccine Doses in Children

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT01164553·243 enrolled

Elderly1 trial

Sanofi H1N1 + TIV - Adults and Elderly

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00943878·805 enrolled

Adult1 trial

FLU-VACS Comparative Study in Adults

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00133523·2,349 enrolled

Rheumatoid Arthritis1 trial

TIV and High Dose TIV in Subjects With Rheumatoid Arthritis

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT01436370·102 enrolled

7 more indications

Tuberculosis1 trial

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

Completed·UUniversity of Witwatersrand, South Africa·Phase 4·NCT01811823·301 enrolled

Respiratory Infections1 trial

Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)

Completed·UUMC Utrecht·Phase 4·NCT00161122·660 enrolled

Pediatric1 trial

Sanofi Pasteur, TIV + H1N1, Pediatric Population

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00943202·531 enrolled

Pneumonia1 trial

Flu Vaccine Against Childhood Pneumonia, Bangladesh

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT01319955·3,508 enrolled

Vaccine1 trial

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Completed·Sanofi·Phase 4·NCT01427309·31,989 enrolled

Immunology1 trial

Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines

Active, not recruiting·WWashington University School of Medicine·Approved·NCT07493460·25 enrolled

Unspecified1 trial

Eldery High Dose TIV 2005

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00115531·414 enrolled

Details

Drug Info

Related News